Scarica l'app Stockscreener
10.26
4.48%
0.44
Precedente Chiudi:
$9.82
Aprire:
$9.76
Volume 24 ore:
1.20M
Relative Volume:
1.06
Capitalizzazione di mercato:
$818.27M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+12.01%
1M Prestazione:
-9.20%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$9.65
$10.37
Intervallo di 1 settimana:
$8.98
$11.29
Portata 52W:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Nome
Niagen Bioscience Inc
Settore
Industria
Telefono
310-388-6706
Indirizzo
10900 WILSHIRE BLVD, LOS ANGELES
Confronta NAGE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
10.26 | 783.17M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-08-16 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2019-10-16 | Iniziato | Oppenheimer | Outperform |
| 2019-02-14 | Iniziato | B. Riley FBR | Buy |
| 2017-11-27 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-01-03 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Niagen Bioscience Inc Borsa (NAGE) Ultime notizie
Niagen Bioscience (NASDAQ:NAGE) Given New $12.00 Price Target at HC Wainwright - MarketBeat
Q2 EPS Forecast for Niagen Bioscience Increased by Analyst - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives $13.22 Average PT from Brokerages - MarketBeat
Niagen Bioscience stock price target raised to $12 from $11 at H.C. Wainwright - Investing.com Canada
Real time scanner hits for Niagen Bioscience Inc. explainedRisk Balanced Picks for Safer Trading - Newser
Niagen Bioscience Reports Strong Q2 Growth and Outlook - TipRanks
Is Niagen Bioscience Inc. a defensive stockFree Investment Webinars - classian.co.kr
News impact scoring models applied to Niagen Bioscience Inc.In-Depth Stock Trading Volume Analysis - Newser
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Earnings Beat - MarketBeat
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN
Roth Capital Cuts Earnings Estimates for Niagen Bioscience - MarketBeat
Risk adjusted return profile for Niagen Bioscience Inc. analyzedSafe and Scalable Return Strategy Blueprint - Newser
Can Niagen Bioscience Inc. rally from current levelsLow Risk Strategy with Smart Entry Zones - Newser
Will a bounce in Niagen Bioscience Inc. offer an exitProven Trading System with Consistent Gains - Newser
Niagen Bioscience, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Earnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of “Buy” by Brokerages - Defense World
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Should you wait for a breakout in Niagen Bioscience Inc.Free Fundamental Growth Stock Analysis - Newser
Niagen Bioscience Reports Strong Q2 Sales Growth - The Globe and Mail
Niagen Bioscience: Q2 Earnings Snapshot - New Haven Register
Niagen Bioscience (NASDAQ:NAGE) Cut to Buy at Wall Street Zen - MarketBeat
Niagen Bioscience shares rise 21.91% premarket after Q2 sales beat estimates. - AInvest
Earnings call transcript: Niagen Bioscience Q2 2025 earnings beat expectations - Investing.com
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - BioSpace
Niagen NAGE Q2 2025 Earnings Call Transcript - Mitrade
Niagen Bioscience shares rise 24.88% after-hours after Q2 sales beat estimates. - AInvest
Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Transcript : Niagen Bioscience, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Niagen Bioscience Q2 2025 presentation: Revenue jumps 37%, ingredient sales surge 135% - Investing.com Nigeria
Niagen Bioscience Q2 2025 presentation: Revenue jumps 37%, ingredient sales surge 135% By Investing.com - Investing.com South Africa
Niagen Bioscience earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Press Release: Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - 富途牛牛
What You Can Learn From Niagen Bioscience, Inc.'s (NASDAQ:NAGE) P/S After Its 28% Share Price Crash - simplywall.st
Niagen Bioscience shares fall 3.53% premarket ahead of CEO's participation in Canaccord Genuity's 45th Annual Growth Conference. - AInvest
Niagen Bioscience Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference - BioSpace
Niagen Bioscience (NASDAQ:NAGE) Stock Rating Lowered by Wall Street Zen - Defense World
Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth Conference - Lelezard
What is the dividend policy of Niagen Bioscience Inc. stockDiscover high-impact investment opportunities - Jammu Links News
What makes Niagen Bioscience Inc. stock price move sharplyTrend Reversal Watch with Entry Signals - Newser
Should I hold or sell Niagen Bioscience Inc. stock in 2025Get daily expert analysis on top stocks - Jammu Links News
What is Niagen Bioscience Inc. company’s growth strategyGet exclusive access to professional stock picks - Jammu Links News
Is Niagen Bioscience Inc. a growth stock or a value stockFree Predictions - Jammu Links News
Why is Niagen Bioscience Inc. stock attracting strong analyst attentionSuperior risk-adjusted returns - Jammu Links News
What are analysts’ price targets for Niagen Bioscience Inc. in the next 12 monthsHigh-profit stock alerts - Jammu Links News
How strong is Niagen Bioscience Inc. company’s balance sheetDiscover high-impact stocks for your portfolio - Jammu Links News
When is Niagen Bioscience Inc. stock expected to show significant growthUnlock powerful trading alerts for success - Jammu Links News
Niagen Bioscience (NASDAQ:NAGE) Shares Up 6%Here's Why - MarketBeat
Niagen Bioscience Inc Azioni (NAGE) Dati Finanziari
Non sono disponibili dati finanziari per Niagen Bioscience Inc (NAGE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):